xmlui.themes.about.link
Departamento de Medicina y Psiquiatría: Envíos recientes
Mostrando ítems 801-820 de 1277
-
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
(Oxford University Press, 2021-11-03) -
Predictors of clinically significant quality of life impairment in Parkinson's disease.
(Nature Publishing Group, 2021-12-16) -
Regional brain and spinal cord volume Loss in spinocerebellar ataxia type 3
(John Wiley and Sons Inc., 2021-10) -
Polyglutamine-expanded ataxin-3: a target engagement marker for spinocerebellar ataxia type 3 in peripheral blood
(John Wiley and Sons Inc., 2021-11) -
Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis
(Elsevier (Cell Press), 2021-02-03) -
Identification of sixteen novel candidate genes for late onset Parkinson's disease
(BioMed Central, 2021-06-21) -
Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease
(American Academy of Neurology, 2021-03) -
Investigation of autosomal genetic sex differences in Parkinson's disease
(Wiley-Liss, 2021-04) -
Identification of candidate parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets
(American Medical Association (AMA), 2021-04) -
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
(Nature Publishing Group, 2021-04-06) -
Ia afferent fibers in peripheral nerve disorders: Evidence for divergent vulnerability
(Elsevier, 2021-04) -
Finding genetically-supported drug targets for Parkinson´s disease using Mendelian randomization of the druggable genome
(Nature Publishing Group, 2021-12)